These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 11979426
1. Acute sodium arsenite treatment induces Cyp2a5 but not Cyp1a1 in the C57Bl/6 mouse in a tissue (kidney) selective manner. Seubert JM, Webb CD, Bend JR. J Biochem Mol Toxicol; 2002; 16(2):96-106. PubMed ID: 11979426 [Abstract] [Full Text] [Related]
2. Acute sodium arsenite administration induces pulmonary CYP1A1 mRNA, protein and activity in the rat. Seubert JM, Sinal CJ, Bend JR. J Biochem Mol Toxicol; 2002; 16(2):84-95. PubMed ID: 11979425 [Abstract] [Full Text] [Related]
3. Effects of acute sodium arsenite administration on the pulmonary chemical metabolizing enzymes, cytochrome P-450 monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase in guinea pig: comparison with effects in liver and kidney. Falkner KC, McCallum GP, Cherian MG, Bend JR. Chem Biol Interact; 1993 Jan; 86(1):51-68. PubMed ID: 8431965 [Abstract] [Full Text] [Related]
4. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2. Abu-Bakar A, Satarug S, Marks GC, Lang MA, Moore MR. Toxicol Lett; 2004 Mar 21; 148(3):199-210. PubMed ID: 15041070 [Abstract] [Full Text] [Related]
5. Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes. Jacobs JM, Nichols CE, Andrew AS, Marek DE, Wood SG, Sinclair PR, Wrighton SA, Kostrubsky VE, Sinclair JF. Toxicol Appl Pharmacol; 1999 May 15; 157(1):51-9. PubMed ID: 10329507 [Abstract] [Full Text] [Related]
6. Selective increase of rat lung cytochrome P450 1A1 dependent monooxygenase activity after acute sodium arsenite administration. Albores A, Sinal CJ, Cherian MG, Bend JR. Can J Physiol Pharmacol; 1995 Jan 15; 73(1):153-8. PubMed ID: 7600446 [Abstract] [Full Text] [Related]
7. The role of stress in the regulation of drug metabolizing enzymes in mice. Konstandi M, Marselos M, Radon-Camus AM, Johnson E, Lang MA. Eur J Drug Metab Pharmacokinet; 1998 Jan 15; 23(4):483-90. PubMed ID: 10323331 [Abstract] [Full Text] [Related]
8. Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa. Su T, He W, Gu J, Lipinskas TW, Ding X. Drug Metab Dispos; 1998 Aug 15; 26(8):822-4. PubMed ID: 9698299 [Abstract] [Full Text] [Related]
9. Effect of arsenite on induction of CYP1A and CYP2H in primary cultures of chick hepatocytes. Jacobs J, Roussel R, Roberts M, Marek D, Wood S, Walton H, Dwyer B, Sinclair P, Sinclair J. Toxicol Appl Pharmacol; 1998 Jun 15; 150(2):376-82. PubMed ID: 9653069 [Abstract] [Full Text] [Related]
10. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite. Spink DC, Katz BH, Hussain MM, Spink BC, Wu SJ, Liu N, Pause R, Kaminsky LS. Drug Metab Dispos; 2002 Mar 15; 30(3):262-9. PubMed ID: 11854143 [Abstract] [Full Text] [Related]
11. Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver. Salonpää P, Krause K, Pelkonen O, Raunio H. Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr 15; 351(4):446-52. PubMed ID: 7543189 [Abstract] [Full Text] [Related]
12. Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium. Elbekai RH, El-Kadi AO. Toxicology; 2004 Oct 01; 202(3):249-69. PubMed ID: 15337587 [Abstract] [Full Text] [Related]
13. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5. Abu-Bakar A, Moore MR, Lang MA. Biochem Pharmacol; 2005 Nov 15; 70(10):1527-35. PubMed ID: 16183037 [Abstract] [Full Text] [Related]
14. Distinct time courses of increase in cytochromes P450 1A2, 2A5 and glutathione S-transferases during the progressive hepatitis associated with Helicobacter hepaticus. Chomarat P, Sipowicz MA, Diwan BA, Fornwald LW, Awasthi YC, Anver MR, Rice JM, Anderson LM, Wild CP. Carcinogenesis; 1997 Nov 15; 18(11):2179-90. PubMed ID: 9395219 [Abstract] [Full Text] [Related]
15. Plasmodium berghei (ANKA): infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver. De-Oliveira AC, Da-Matta AC, Paumgartten FJ. Exp Parasitol; 2006 Aug 15; 113(4):256-61. PubMed ID: 16540109 [Abstract] [Full Text] [Related]
16. Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes. Camus-Randon AM, Raffalli F, Béréziat JC, McGregor D, Konstandi M, Lang MA. Toxicol Appl Pharmacol; 1996 May 15; 138(1):140-8. PubMed ID: 8658503 [Abstract] [Full Text] [Related]
17. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions. Wastl UM, Rossmanith W, Lang MA, Camus-Randon AM, Grasl-Kraupp B, Bursch W, Schulte-Hermann R. Mol Carcinog; 1998 Aug 15; 22(4):229-34. PubMed ID: 9726815 [Abstract] [Full Text] [Related]
18. Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes. Kojo A, Viitala P, Pasanen M, Pelkonen O, Raunio H, Juvonen R. Arch Toxicol; 1998 May 15; 72(6):336-41. PubMed ID: 9657280 [Abstract] [Full Text] [Related]
19. The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+. Elbekai RH, El-Kadi AO. Free Radic Biol Med; 2005 Dec 01; 39(11):1499-511. PubMed ID: 16274885 [Abstract] [Full Text] [Related]
20. Differential in vivo effects of alpha-naphthoflavone and beta-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney. Sinal CJ, Webb CD, Bend JR. J Biochem Mol Toxicol; 1999 Dec 01; 13(1):29-40. PubMed ID: 9890445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]